-- Days : -- HRS : -- MIN : -- SEC

Register Now →

News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Kimberly A. McGuigan, PhD

Articles by Kimberly A. McGuigan, PhD

Are There Unintended Consequences of Step-Therapy Programs?

ByEmily R. Cox, RPh, PhD,Brian J. Seiz, PharmD. Reply by Tami L. Mark, PhD, MBA,Teresa B. Gibson, PhD,Kimberly A. McGuigan, PhD

September 7th 2009

The Effects of Antihypertensive Step-Therapy Protocols on Pharmaceutical and Medical Utilization and Expenditures

ByTami L. Mark, PhD, MBA,Teresa B. Gibson, PhD,Kimberly A. McGuigan, PhD

February 14th 2009

Step therapy with antihypertensives may lead to medication cost savings but may have unintended effects on other medical care utilization and spending.

The Effects of Prescription Drug Copayments on Statin Adherence

ByTeresa B. Gibson, PhD,Tami L. Mark, PhD,Kimberly A. McGuigan, PhD,Kirsten Axelsen, MS,Shaohung Wang, PhD

September 1st 2006

Latest Updated Articles

The Effects of Antihypertensive Step-Therapy Protocols on Pharmaceutical and Medical Utilization and Expenditures
February 14th 2009
The Effects of Prescription Drug Copayments on Statin Adherence
September 1st 2006
Are There Unintended Consequences of Step-Therapy Programs?
September 7th 2009

Trending on AJMC

FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer

FDA Panel Backs 6 Peptides for Compounding

Atacicept Becomes First BAFF/APRIL Inhibitor Approved for IgA Nephropathy: Richard Lafayette, MD

Boston Panel Confronts Access and Coordination Gaps in Obesity Care

Pediatric Chronic Skin Disorders Linked to Poorer Mental Health